Shanghai United Imaging Healthcare Co., Ltd. (SHA:688271)
China · Delayed Price · Currency is CNY 103.11
+0.75 (0.73%)
Sep 11, 2026, 3:00 PM CST
SHA:688271 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 84,282 | 102,913 | 103,516 | 112,918 | 145,859 | - | |
Market Cap Growth | -32.51% | -0.58% | -8.33% | -22.58% | - | - |
Enterprise Value | 77,136 | 95,206 | 94,565 | 101,052 | 133,488 | - |
Last Close Price | 103.11 | 125.14 | 125.86 | 135.97 | 175.38 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 47.53 | 55.05 | 82.03 | 57.19 | 88.08 | - |
Forward PE | 34.83 | 49.88 | 50.26 | 60.36 | 68.86 | - |
PS Ratio | 5.68 | 7.46 | 10.05 | 9.90 | 15.79 | - |
PB Ratio | 3.83 | 4.77 | 5.20 | 5.98 | 8.35 | - |
P/TBV Ratio | 4.21 | 5.14 | 5.48 | 6.27 | 8.79 | - |
P/FCF Ratio | - | 175.67 | - | - | - | - |
P/OCF Ratio | 35.29 | 38.41 | - | 852.14 | 213.62 | - |
PEG Ratio | 2.99 | 1.83 | 7.14 | 2.77 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.20 | 6.90 | 9.18 | 8.86 | 14.45 | - |
EV/EBITDA Ratio | 30.70 | 40.98 | 70.63 | 51.36 | 77.78 | - |
EV/EBIT Ratio | 41.83 | 52.13 | 98.57 | 61.10 | 91.88 | - |
EV/FCF Ratio | - | 162.51 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.06 | 0.03 | 0.01 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.72 | 0.53 | 0.50 | 0.08 | 0.08 | 0.09 |
Debt / FCF Ratio | - | 2.13 | - | - | - | 0.26 |
Net Debt / Equity Ratio | -0.32 | -0.43 | -0.47 | -0.65 | -0.80 | -0.62 |
Net Debt / EBITDA Ratio | -2.92 | -3.95 | -7.04 | -6.27 | -8.14 | -1.91 |
Net Debt / FCF Ratio | 98.59 | -15.67 | 3.67 | 13.09 | 238.59 | -5.20 |
Asset Turnover | 0.47 | 0.45 | 0.39 | 0.46 | 0.54 | 0.73 |
Inventory Turnover | 1.20 | 1.30 | 1.12 | 1.65 | 1.71 | 1.86 |
Quick Ratio | 1.51 | 1.79 | 2.11 | 2.77 | 2.72 | 1.02 |
Current Ratio | 2.29 | 2.47 | 2.95 | 3.49 | 3.35 | 1.56 |
Return on Equity (ROE) | 8.15% | 8.89% | 6.40% | 10.88% | 14.66% | 32.48% |
Return on Assets (ROA) | 3.65% | 3.75% | 2.25% | 4.17% | 5.25% | 8.67% |
Return on Invested Capital (ROIC) | 11.22% | 14.87% | 10.36% | 30.40% | 45.88% | 78.22% |
Return on Capital Employed (ROCE) | 7.60% | 7.80% | 4.60% | 8.50% | 8.00% | 23.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.10% | 1.82% | 1.22% | 1.75% | 1.14% | - |
FCF Yield | -0.09% | 0.57% | -2.48% | -0.83% | -0.04% | - |
Dividend Yield | 0.29% | 0.25% | 0.16% | 0.18% | 0.11% | - |
Payout Ratio | 10.42% | 9.42% | 24.06% | 8.41% | 0.06% | 0.57% |
Buyback Yield / Dilution | 0.86% | -0.06% | 0.39% | -8.78% | -4.58% | -3.99% |
Total Shareholder Return | 1.14% | 0.19% | 0.55% | -8.60% | -4.47% | -3.99% |